Aneurysm: Clinical Trials

4 trials for Aneurysm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Terminated 4

Follow Aneurysm: new trials by email Literature Review of Aneurysm trials Research Report on Aneurysm

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms
1 million MSCs/kg, 3 million MSCs/kg, Placebo - Abdominal Aortic Aneurysm
Phase 1TerminatedVA Office of Research and Development282016-12-052024-08-09
Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH
EG-1962 (nimodipine microparticles), Enteral Nimodipine - Subarachnoid Hemorrhage, Aneurysmal
Phase 1TerminatedEdge Therapeutics Inc62016-09-012018-07-26
Evaluation of a New Imagingtechnologie for Thrombosis
[18F]-GP1 - Abdominal Aortic Aneurysm, Deep Vein Thrombosis
Phase 1TerminatedUniversity of Zurich42014-09-012017-05-09
Peripheral Vasodilation in Obese Humans
Drug Trial 1 (EDD), Drug Trial 2 (ROV) - Obesity
Phase 1TerminatedUniversity of Wisconsin, Madison82012-04-162022-02-11

Narrower conditions

Aortic Aneurysm, Abdominal (2)  ·  Aortic Aneurysm (1)  ·  Obesity (1)  ·  Rupture (1)  ·  Subarachnoid Hemorrhage (1)  ·  Venous Thrombosis (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Vascular Diseases (4)  ·  Aortic Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Aortic Aneurysm (1)  ·  Body Weight (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Embolism and Thrombosis (1)  ·  Hemorrhage (1)  ·  Intracranial Hemorrhages (1)  ·  Nervous System Diseases (1)  ·  Nutrition Disorders (1)

Interventions

EG-1962 (1)  ·  Plasmalyte A (1)  ·  UBR5 protein, human (1)

Sponsors

Edge Therapeutics Inc (1)  ·  University of Wisconsin, Madison (1)  ·  University of Zurich (1)  ·  VA Office of Research and Development (1)

Countries

United States (3)  ·  Canada (1)  ·  Switzerland (1)

Top investigators

Michael P Murphy, MD BS (1)  ·  Philipp A Kaufmann, Prof (1)  ·  R. Loch Macdonald, MD, PhD (1)  ·  William Schrage, Ph.D. (1)

Results publications

PMID 32985652, PMID 37624739

NIH funding

R01HL105820 (1)